home / stock / inkt / inkt articles

INKT Articles, MiNK Therapeutics Inc. - From 06/05/24

Stock Information
Company Name: MiNK Therapeutics Inc.
Stock Symbol: INKT
Market: NASDAQ
Website: minktherapeutics.com
Menu
INKT INKT Quote INKT Short INKT News INKT Articles INKT Message Board
Get INKT Alerts

News, Short Squeeze, Breakout and More Instantly...
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting | Benzinga

NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ:INKT), a clinical-stage biopharmaceutical company pioneering the dis...
MiNK Reports First Quarter 2024 Results | Benzinga

Completed $5.8 million private placement financing at 25% premium Upcoming presentation of agenT-797 in severe respiratory distress at the Ameri...

Why MiNK Therapeutics Stock Is Up 11% Monday | Benzinga

MiNK Therapeutics, Inc. (NASDAQ:INKT) shares are trading higher Monday after the clinical-stage biopharmaceutical company announced private placeme...

MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer | Benzinga

Financing of $5.8 Million at a 25% premium will help advance the clinical development of MiNK-215, an armored-FAP-CAR-iNKT GKCC, LLC joins as a ...
MiNK to Provide Corporate Update and First Quarter 2024 Financial Report | Benzinga

NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ:INKT), a clinical-stage biopharmaceutical company pioneering the di...

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-q...

MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR 2024 | Benzinga

NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ:INKT), a clinical-stage biopharmaceutical company pioneering the di...
MiNK Therapeutics Reports Third Quarter 2023 Results | Benzinga

MiNK presents first-of-a-kind data with allogeneic iNKTs, agenT-797, showing durable clinical benefit in solid tumor cancers and persistence >...

Sacks Parente Golf And 3 Other Stocks Under $2 Insiders Are Buying | Benzinga

The Dow Jones closed higher by more than 300 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern arou...

Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying | Benzinga

The Dow Jones closed higher by around 290 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around ...
Previous 10 Next 10